SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ajanta Pharma
Ajanta Pharma
BSE: 532331|NSE: AJANTPHARM|ISIN: INE031B01049|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 12, 16:00
1311.00
11.1 (0.85%)
VOLUME 85,353
LIVE
NSE
Feb 12, 15:55
1311.65
8.95 (0.69%)
VOLUME 240,925
News on Ajanta Pharma
Select Year: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Sell CESC, HPCL; UPL may head lower: Sudarshan Sukhani 

9.13 am | 10 Feb 2016 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends selling CESC and HPCL and feels that UPL may head lower....

Bull's Eye: Buy CESC, HDIL, Siemens; sell Arvind, Ajanta Pharma 

8.07 am | 09 Feb 2016 |  Source: CNBC-TV18

Ruchit Jain of Angel Broking advises selling Arvind Future with a target of Rs 274....

Go long in Cadila Health, Axis Bank, Allahabad Bank: Gaba 

9.37 am | 08 Feb 2016 |  Source: CNBC-TV18

Prakash Gaba of prakashgaba.com recommends going long in Cadila Healthcare and Axis Bank and Allahabad Bank....

Buy Ajanta Pharma; target of Rs 1780: ICICIDirect

6.08 pm | 05 Feb 2016 |  Source: Moneycontrol.com

ICICIDirect is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target price of Rs 1780 in its research report dated Februa...

Buy Ajanta Pharma, Havells India, Tata Elxsi: Ashish Kyal 

3.58 pm | 02 Feb 2016 |  Source: CNBC-TV18

Ashish Kyal of wavesstrategy.com recommends buying Ajanta Pharma, Havells India and Tata Elxsi....

Buy Ajanta Pharma on dips, sell PSU banks: Sudarshan Sukhani 

3.52 pm | 01 Feb 2016 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Ajanta Pharma on dips....

Ajanta Pharma Q3 net up 20% at Rs 111.3 crore

3.49 pm | 01 Feb 2016 |  Source: PTI

The company had posted a net profit of Rs 93.06 crore for the same period of the previous fiscal. Net sales of the company rose to Rs 465.71 crore for...

Like Ajanta Pharma, HUL may test Rs 815-820: Prakash Gaba 

10.36 am | 29 Jan 2016 |  Source: CNBC-TV18

Prakash Gaba of prakashgaba.com likes Ajanta Pharma and feels that Hindustan Unilever may move up and test Rs 815-820....

Here are Manoj Murlidharan’s top F&O picks 

10.19 am | 28 Jan 2016 |  Source: CNBC-TV18

In an interview to CNBC-TV18's Latha Venkatesh and Sonia Shenoy, Manoj Murlidharan of Religare Securities and Yogesh Radke of Edelweiss Securities gav...

Buy Ajanta Pharma, ITC, Power Grid; sell Marico: Prakash Gaba 

12.13 pm | 27 Jan 2016 |  Source: CNBC-TV18

Prakash Gaba of prakashgaba.com is of the view that one can buy Ajanta Pharma, ITC and Power Grid and advises selling Marico....

Ajanta Pharma's Q3 results on February 01, 2016

10.23 am | 18 Jan 2016 |  Source: Moneycontrol.com

Ajanta Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 1, 2016, inter alia, to consider a...

Buy Sun Pharma; sell Tata Motors, IFCI: Sudarshan Sukhani 

10.04 am | 18 Jan 2016 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Sun Pharma and Apollo Hospitals and advises selling Tata Motors and IFCI....

1
Quick Links for Ajanta Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.